Nabumetone and Thalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nabumetone (nabumetone) and Thalidomide (thalidomide). Common drug interactions include diabetes mellitus among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Nabumetone and Thalidomide. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Nabumetone?

Nabumetone has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 9,554 Nabumetone users. Check the latest studies of Nabumetone.

What is Thalidomide?

Thalidomide has active ingredients of thalidomide. eHealthMe is studying from 16,473 Thalidomide users. Check the latest studies of Thalidomide.



On Jul, 26, 2026

28 people who take Nabumetone and Thalidomide together, and have interactions are studied.

Nabumetone and Thalidomide drug interactions.

What are the common drug interactions of Nabumetone and Thalidomide, by gender? *:

female:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Arthralgia (joint pain)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Confusional state
  5. Haemorrhage (bleeding)
  6. Infected skin ulcer
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)
  9. Spinal column injury (spinal cord bone injury)
  10. Atelectasis (partial or complete collapse of the lung)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Lung neoplasm malignant (cancer tumour of lung)
  4. Osteomyelitis (infection of bone)
  5. Osteonecrosis (death of bone)
  6. Physical disability
  7. Prostate cancer
  8. Prostatic specific antigen increased
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)

What are the common drug interactions of Nabumetone and Thalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Activities of daily living impaired
  2. Anaemia (lack of blood)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Aphasia (damage to the parts of the brain that control language)
  6. Arthralgia (joint pain)
  7. Back pain
  8. Balance disorder
  9. Blood antidiuretic hormone decreased
  10. Brain neoplasm (tumour of brain)

50-59:

  1. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  2. Diastolic dysfunction
  3. Disease progression
  4. Dyspnoea (difficult or laboured respiration)
  5. Erythema (redness of the skin)
  6. Gingival erythema (redness of gums)
  7. Gingival infection (gum infection)
  8. Gingival pain (gum pain)
  9. Hypermetropia (abnormal condition in which vision for distant objects is better than for near objects)
  10. Hypertensive heart disease

60+:

  1. Blood lactate dehydrogenase increased
  2. Anaemia (lack of blood)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Ear pain
  5. Escherichia infection (bacterial infection by escherichia coli)
  6. Facial bones fracture (bone fracture of face)
  7. Fall
  8. Gingival bleeding (bleeding gums)
  9. Gingival swelling (gums swelling)
  10. Hip fracture

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 6 people, 21.43%
  2. Osteoporosis (bones weak and more likely to break): 5 people, 17.86%
  3. Behcet's Syndrome (involves inflammation of the blood vessels): 5 people, 17.86%
  4. Neoplasm Malignant (cancer tumour): 2 people, 7.14%
  5. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 7.14%
  6. Anaemia (lack of blood): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Nabumetone and Thalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nabumetone and Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nabumetone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nabumetone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on nabumetone and thalidomide (the active ingredients of Nabumetone and Thalidomide, respectively), and Nabumetone and Thalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: